Meritage Portfolio Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,547
Closed -$1.08M 336
2025
Q1
$1.08M Buy
3,547
+336
+10% +$113K 0.07% 185
2024
Q4
$1.07M Buy
3,211
+142
+5% +$48.2K 0.07% 191
2024
Q3
$1.02M Buy
3,069
+306
+11% +$116K 0.06% 199
2024
Q2
$1.14M Buy
2,763
+30
+1% +$11.9K 0.07% 191
2024
Q1
$1.1M Sell
2,733
-253
-8% -$89K 0.07% 196
2023
Q4
$915K Buy
2,986
+158
+6% +$42.6K 0.06% 202
2023
Q3
$685K Buy
2,828
+146
+5% +$37.3K 0.05% 215
2023
Q2
$644K Buy
2,682
+799
+42% +$166K 0.05% 222
2023
Q1
$354K Buy
1,883
+80
+4% +$16.5K 0.03% 231
2022
Q4
$383K Buy
1,803
+46
+3% +$9.19K 0.03% 234
2022
Q3
$276K Buy
1,757
+143
+9% +$22.8K 0.02% 257
2022
Q2
$242K Sell
1,614
-121
-7% -$17.5K 0.02% 271
2022
Q1
$284K Sell
1,735
-69,803
-98% -$11.5M 0.02% 280
2021
Q4
$15.6M Sell
71,538
-459
-0.6% -$96.1K 0.88% 25
2021
Q3
$13.6M Buy
71,997
+442
+0.6% +$80.6K 0.82% 27
2021
Q2
$12.6M Sell
71,555
-705
-1% -$122K 0.76% 28
2021
Q1
$11.9M Sell
72,260
-1,922
-3% -$294K 0.79% 27
2020
Q4
$10.3M Buy
74,182
+1,017
+1% +$128K 0.76% 33
2020
Q3
$8.18M Sell
73,165
-99
-0.1% -$11.4K 0.73% 34
2020
Q2
$6.82M Buy
73,264
+2,947
+4% +$251K 0.66% 37
2020
Q1
$5.16M Buy
+70,317
New +$6.1M 0.7% 36

Other funds holding MEDP

Meritage Portfolio Management's MEDP Position: Q2 2025 in Review

Meritage Portfolio Management sold out of Medpace (MEDP) in Q2 2025, closing a stake of 3,547 shares — an estimated $1.08M sold.

Meritage Portfolio Management first reported a position in MEDP in Q1 2020 and held it in 21 quarters. The position peaked at $15.6M in Q4 2021. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Meritage Portfolio Management reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Meritage Portfolio Management sold 3,547 Medpace shares in Q2 2025, an estimated $1.08M.
  • Meritage Portfolio Management first reported a position in Medpace in Q1 2020 and held it in 21 quarters.
  • Meritage Portfolio Management's Medpace position peaked at $15.6M in Q4 2021.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Meritage Portfolio Management's 13F filing for Q2 2025, filed 25 Jul 2025.